Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
Fuente:
Redalyc
Saved in:
| Main Author: | Seeba Zachariah |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Centro de investigaciones y Publicaciones Farmacéuticas
2020
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies
by: Go Shinke, et al.
Published: (2024)
by: Go Shinke, et al.
Published: (2024)
Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
by: Ali Scrimenti
Published: (2019)
by: Ali Scrimenti
Published: (2019)
New anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries. A systematic review of randomized controlled trials
by: Ricardo de Alvarenga Yoshida
Published: (2012)
by: Ricardo de Alvarenga Yoshida
Published: (2012)
Clinical significance of recurrent venous thromboembolism
by: Nicos Labropoulos
Published: (2010)
by: Nicos Labropoulos
Published: (2010)
Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
by: Miroslav Durila, et al.
Published: (2024)
by: Miroslav Durila, et al.
Published: (2024)
Estimated impact of model‐guided venous thromboembolism prophylaxis versus real‐world practice
by: Benjamin G Mittman, et al.
Published: (2026)
by: Benjamin G Mittman, et al.
Published: (2026)
Hospital‐associated venous thromboembolism prophylaxis use by risk assessment at a large integrated health care network in Northern California
by: James Xu, et al.
Published: (2024)
by: James Xu, et al.
Published: (2024)
Safety and efficacy of anti‐coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience
by: Vilmarie Rodriguez, et al.
Published: (2026)
by: Vilmarie Rodriguez, et al.
Published: (2026)
Assessment of non-cardiac surgical patients using the ACS-NSQIP calculator to predict the risk of pneumonia, cardiac complications and venous thromboembolism
by: INDHIRA PACHANO-GARCÍA
Published: (2021)
by: INDHIRA PACHANO-GARCÍA
Published: (2021)
Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
by: Tyler Chanas, et al.
Published: (2024)
by: Tyler Chanas, et al.
Published: (2024)
Individualización posológica de enoxaparina en un obeso extremo mediante la monitorización del factor anti-Xa
by: Arantxa Andujar Mateos
Published: (2016)
by: Arantxa Andujar Mateos
Published: (2016)
Clonal haemopoiesis and venous thromboembolism risk
by: David P. Steensma
Published: (2024)
by: David P. Steensma
Published: (2024)
A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism
by: Fady Allahwerdy
Published: (2019)
by: Fady Allahwerdy
Published: (2019)
Risk factors for deep venous thrombosis in patients undergoing orthopedic surgical procedures
by: Marco Antonio González Fuenmayor
Published: (2022)
by: Marco Antonio González Fuenmayor
Published: (2022)
DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin
by: Sophie Melicine, et al.
Published: (2024)
by: Sophie Melicine, et al.
Published: (2024)
New horizons in the pharmacological management of venous thromboembolism
by: Andreas Verstraete, et al.
Published: (2025)
by: Andreas Verstraete, et al.
Published: (2025)
Navigating venous thromboembolism risks in lung cancer patients
by: Si‐Wai Vivian Chiu, et al.
Published: (2024)
by: Si‐Wai Vivian Chiu, et al.
Published: (2024)
Peculiaridades da terapia trombolítica na síndrome nefrótica pediátrica: monitorização do fator anti-Xa
by: Patrícia Zambi Meirelles
Published: (2008)
by: Patrícia Zambi Meirelles
Published: (2008)
Venous thromboembolism prevention protocol for adapting prophylaxis recommendations to the potential risk post total knee replacement: a randomized controlled trial
by: Mariam A. Alameri
Published: (2020)
by: Mariam A. Alameri
Published: (2020)
Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases
by: Maren E. Buenning, et al.
Published: (2025)
by: Maren E. Buenning, et al.
Published: (2025)
Clinical guideline highlights for the hospitalist: Management of pediatric venous thromboembolism
by: Carly Noel, et al.
Published: (2026)
by: Carly Noel, et al.
Published: (2026)
Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly
by: Javier Ena, et al.
Published: (2024)
by: Javier Ena, et al.
Published: (2024)
Attention to the risk of venous thromboembolism in mechanically restrained hospitalised patients
by: Adrian Chee, et al.
Published: (2024)
by: Adrian Chee, et al.
Published: (2024)
Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
by: Sheng Li, et al.
Published: (2025)
by: Sheng Li, et al.
Published: (2025)
Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías
Published: (2016)
by: Isabel Elías
Published: (2016)
Association between venous thromboembolism‐associated genetic variants, coagulation factor levels, and thrombin generation potential
by: Jihee Han, et al.
Published: (2024)
by: Jihee Han, et al.
Published: (2024)
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
by: Qian Li, et al.
Published: (2024)
by: Qian Li, et al.
Published: (2024)
Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay
by: Renata Jurema Medeiros
Published: (2023)
by: Renata Jurema Medeiros
Published: (2023)
The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials
by: Loay A. Salman, et al.
Published: (2024)
by: Loay A. Salman, et al.
Published: (2024)
Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty
by: Nameer van Oosterom, et al.
Published: (2024)
by: Nameer van Oosterom, et al.
Published: (2024)
Pulmonary thromboembolism in an anticoagulated oncological patient
by: Diana Alegre-González
Published: (2023)
by: Diana Alegre-González
Published: (2023)
Three cases of neutralization of factor Xa inhibitors with andexanet alfa under rotational thromboelastography monitoring
by: Takeshi Yagi, et al.
Published: (2024)
by: Takeshi Yagi, et al.
Published: (2024)
Comparison of four D ‐dimer assays in the context of venous thromboembolism in the emergency department
by: Fabio Del Ben, et al.
Published: (2024)
by: Fabio Del Ben, et al.
Published: (2024)
Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
by: Lara N. Roberts, et al.
Published: (2024)
by: Lara N. Roberts, et al.
Published: (2024)
Symptomatic and asymptomatic venous thromboembolism after minimally invasive surgery for gynecological cancers
by: Michiko Kubo‐Kaneda, et al.
Published: (2025)
by: Michiko Kubo‐Kaneda, et al.
Published: (2025)
Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review
by: Kevin Rajon
Published: (2017)
by: Kevin Rajon
Published: (2017)
Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC‐MS and anti‐Xa assay?
by: Henriette Røed‐Undlien, et al.
Published: (2024)
by: Henriette Røed‐Undlien, et al.
Published: (2024)
Current surgical management of chronic thromboembolic pulmonary disease
by: Hayley Barnes, et al.
Published: (2024)
by: Hayley Barnes, et al.
Published: (2024)
Synchronous eyelid oncocytoma and conjunctival intraepithelial neoplasia
by: Zachariah Chowdhury
Published: (2021)
by: Zachariah Chowdhury
Published: (2021)
Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
by: Giorgia Lodetti
Published: (2023)
by: Giorgia Lodetti
Published: (2023)
Similar Items
-
Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies
by: Go Shinke, et al.
Published: (2024) -
Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
by: Ali Scrimenti
Published: (2019) -
New anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries. A systematic review of randomized controlled trials
by: Ricardo de Alvarenga Yoshida
Published: (2012) -
Clinical significance of recurrent venous thromboembolism
by: Nicos Labropoulos
Published: (2010) -
Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
by: Miroslav Durila, et al.
Published: (2024)